Latest Data & Signals Issued

Signal Type Signal Value Data
Score -4.132 12 days ( 28.63 % )
Last Price $0.195 0.516 %
High/ Low $0.193 - $0.204 12.18%
Chg 7 Days 7.03 % $0.182 $0.195
Chg 30 Days -51.23 % $0.400 $0.195
Chg 12 mos -92.73 % $2.68 $0.195
Trend - 3 mos -33.38 % Width: 116.80 %
Trend - 12 mos -84.95 % Width: 235.01 %
Pred. range - 3 mos $0.106 - $0.229 -45.71 % - 17.70 %
Pred. range - 12 mos N/A - $0.0637 -100.00 % - -67.33 %
Short MA avg 3 mos Buy Dec 02, 2024 - 5 days
Long MA avg 3 mos Buy Nov 11, 2024 - 19 days
Short/Long MA avg 3 mos Sell Nov 14, 2024 - 16 days
Short MA avg 12 mos Sell Nov 08, 2024 - 20 days
Long MA avg 12 mos Sell Nov 30, -0001 - N/A days
Short/Long MA avg 12 mos Sell Nov 30, -0001 - N/A days
Pivot Short Buy Nov 26, 2024 - 8 days
Bollinger Buy Nov 20, 2024 - 12 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!
ABOUT APTOSE BIOSCIENCES
Aptose Biosciences
Aptose Biosciences Inc., a clinical-stage biotechnology company, discovers and develops personalized therapies addressing unmet medical needs in oncology primarily in the United States. Its clinical programs include APTO-253, which is in Phase 1a/b clinical trial for the treatment of patients with relapsed or refractory blood cancers, including acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (HR MDS); and HM43239 that is in Ph...
GOLDEN STAR
Ticker Change Signal Date
NYT
$54.61
2.98% Dec 04
V
VCSH
$78.49
0.140% Dec 04
V
VGSH
$58.30
0.103% Dec 04
S
SLQD
$49.95
0.160% Dec 04
I
ISTB
$48.00
0.208% Dec 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE